Hyperkalemia: Difference between revisions
From IDWiki
(Imported from text file) |
No edit summary |
||
Line 1: | Line 1: | ||
== |
== Background == |
||
* Serum potassium above 5mmol/L |
* Serum potassium above 5mmol/L |
||
== Pathophysiology == |
=== Pathophysiology === |
||
* 98% of total body potassium is intracellular |
* 98% of total body potassium is intracellular |
||
Line 11: | Line 11: | ||
* Normally excreted in the urine |
* Normally excreted in the urine |
||
** Aldosterone stimulates ENAC channels and Na-K channels |
** Aldosterone stimulates ENAC channels and Na-K channels |
||
== Clinical Manifestations == |
|||
⚫ | |||
⚫ | |||
⚫ | |||
⚫ | |||
== Differential Diagnosis == |
== Differential Diagnosis == |
||
Line 16: | Line 22: | ||
* Decreased excretion |
* Decreased excretion |
||
** Decreased aldosterone |
** Decreased aldosterone |
||
*** Primary adrenal insufficiency |
*** [[Primary adrenal insufficiency]] |
||
*** Secondary adrenal insufficiency |
*** Secondary adrenal insufficiency |
||
**** ACE inhibitors |
**** [[ACE inhibitors]] |
||
**** Angiotensin |
**** [[Angiotensin receptor blockers]] |
||
**** Renin inhibitors |
**** [[Renin inhibitors]] |
||
**** NSAIDs |
**** [[NSAIDs]] |
||
**** Congenital adrenal hyperplasia |
**** [[Congenital adrenal hyperplasia]] |
||
** Decreased aldosterone responsiveness |
** Decreased aldosterone responsiveness |
||
*** Spironolactone |
*** [[Spironolactone]] |
||
*** Amiloride |
*** [[Amiloride]] |
||
** Decreased sodium delivery to kidneys |
** Decreased sodium delivery to kidneys |
||
*** Hypovolemia |
*** [[Hypovolemia]] |
||
*** Heart failure |
*** [[Heart failure]] |
||
*** Cirrhosis |
*** [[Cirrhosis]] |
||
*** Nephrotic syndrome |
*** [[Nephrotic syndrome]] |
||
* Increased intake |
* Increased intake |
||
** Iatrogenic |
** Iatrogenic |
||
* Shifts |
* Shifts |
||
** Rhabdomyolysis |
** [[Rhabdomyolysis]] |
||
** Tumour lysis syndrome |
** [[Tumour lysis syndrome]] |
||
** Acidosis |
** [[Acidosis]] |
||
** Drugs |
** Drugs |
||
*** Hypoinsulinemia |
*** [[Hypoinsulinemia]] |
||
*** Beta blockers |
*** [[Beta blockers]] |
||
*** Digoxin |
*** [[Digoxin]] |
||
*** Succinylcholine |
*** [[Succinylcholine]] |
||
** Hemolysis |
** [[Hemolysis]] |
||
** Anemia |
** [[Anemia]] |
||
** Increased plasma osmolality |
** Increased plasma osmolality |
||
* Factitious |
* Factitious |
||
** Hemolysed samples |
** Hemolysed samples |
||
** Increased white cell count |
** Increased white cell count |
||
*** Chronic lymphocytic leukemia |
*** [[Chronic lymphocytic leukemia]] |
||
** Increased platelets |
** Increased platelets |
||
== Complications == |
|||
⚫ | |||
⚫ | |||
⚫ | |||
⚫ | |||
== Management == |
== Management == |
Latest revision as of 17:27, 14 June 2021
Background
- Serum potassium above 5mmol/L
Pathophysiology
- 98% of total body potassium is intracellular
- Gradient maintained by
- Na-K antiporters (3Na:2K)
- H-K antiporter
- Normally excreted in the urine
- Aldosterone stimulates ENAC channels and Na-K channels
Clinical Manifestations
- Arrythmias
- Muscle paralysis (tetany)
Differential Diagnosis
- Decreased excretion
- Decreased aldosterone
- Primary adrenal insufficiency
- Secondary adrenal insufficiency
- Decreased aldosterone responsiveness
- Decreased sodium delivery to kidneys
- Decreased aldosterone
- Increased intake
- Iatrogenic
- Shifts
- Rhabdomyolysis
- Tumour lysis syndrome
- Acidosis
- Drugs
- Hemolysis
- Anemia
- Increased plasma osmolality
- Factitious
- Hemolysed samples
- Increased white cell count
- Increased platelets
Management
- EKG
- Repeat serum potassium
- Pharmacologic treatment indicated if EKG changes
- Stabilize
- Calcium gluconate 1g IV push q30min prn EKG changes
- Lasts 30-60 minutes
- Repeat EKG in 30 minutes, then can give another 1g
- Calcium gluconate 1g IV push q30min prn EKG changes
- Shift
- Insulin R 10 unites in 1 amp D50W
- Albuterol 8-10 puffs
- Bicarbonate
- No evidence of benefit and increases serum sodium
- Excrete
- Kayexalate and lactulose
- Takes 2-3 days to work
- Normal saline
- If not hypovolemic and not on ACEi or ARB, furosemide
- If refractory to medical management, dialysis
- Kayexalate and lactulose